This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
ME/CFS Science
mecfsscience.org
did:plc:ith7dzcppw7ru2enoauywkld
5) Scheibenbogen said they have funding for the plasma/CD38 study through private funding and a foundation. Sanofi owns the medication they want to trial (so the drug is probably Isatuximab = Sarclisa) and they are interested in testing it further with them.
2025-09-25T15:01:54.754Z